DD148776A5 - Verfahren zur herstellung neuer phenanthrolinderivate - Google Patents

Verfahren zur herstellung neuer phenanthrolinderivate Download PDF

Info

Publication number
DD148776A5
DD148776A5 DD80218467A DD21846780A DD148776A5 DD 148776 A5 DD148776 A5 DD 148776A5 DD 80218467 A DD80218467 A DD 80218467A DD 21846780 A DD21846780 A DD 21846780A DD 148776 A5 DD148776 A5 DD 148776A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
carbon atoms
salt
compound
oxo
Prior art date
Application number
DD80218467A
Other languages
German (de)
English (en)
Inventor
Georges Haas
Knut A Jaeggi
Alberto Rossi
Alex Sele
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DD148776A5 publication Critical patent/DD148776A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DD80218467A 1979-01-16 1980-01-15 Verfahren zur herstellung neuer phenanthrolinderivate DD148776A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH40279 1979-01-16

Publications (1)

Publication Number Publication Date
DD148776A5 true DD148776A5 (de) 1981-06-10

Family

ID=4186203

Family Applications (1)

Application Number Title Priority Date Filing Date
DD80218467A DD148776A5 (de) 1979-01-16 1980-01-15 Verfahren zur herstellung neuer phenanthrolinderivate

Country Status (15)

Country Link
US (1) US4297358A (es)
EP (1) EP0013666A1 (es)
JP (1) JPS5598182A (es)
AU (1) AU5460980A (es)
DD (1) DD148776A5 (es)
DK (1) DK16480A (es)
ES (5) ES487661A0 (es)
FI (1) FI800100A (es)
GR (1) GR70371B (es)
IL (1) IL59130A0 (es)
NO (1) NO800085L (es)
NZ (1) NZ192622A (es)
PL (1) PL221367A1 (es)
PT (1) PT70695A (es)
ZA (1) ZA80254B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652567A (en) * 1985-03-13 1987-03-24 Hoechst-Roussel Pharmaceuticals Inc. Benzo(c)-1,5-naphthyridines useful for treating a patient having drug induced memory impairment in need of memory enhancement
JP2008507276A (ja) * 2004-07-23 2008-03-13 ポルノクス コーポレーション 抗酸化マクロモノマーおよび抗酸化ポリマー、ならびにその製造方法および使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313817A (en) * 1964-01-27 1967-04-11 Sterling Drug Inc 4-alkyl (and alkenyl)-1-oxo-1, 4-dihydro-4, 7-phenanthroline-2-carboxylic acid derivatives
CA995670A (en) * 1970-10-05 1976-08-24 Wilson S. Waring Phenanthrolines and pyrido-quinolines
US4156726A (en) * 1974-12-07 1979-05-29 Fisons Limited 4-Oxo-2-carboxyl quinoline derivatives used as antiallergic compounds

Also Published As

Publication number Publication date
ES494603A0 (es) 1981-08-16
ES8106522A1 (es) 1981-08-16
ES8106519A1 (es) 1981-08-16
PL221367A1 (es) 1980-12-01
NZ192622A (en) 1982-03-16
EP0013666A1 (de) 1980-07-23
AU5460980A (en) 1980-07-24
ES494605A0 (es) 1981-08-16
ES8102127A1 (es) 1980-12-16
IL59130A0 (en) 1980-05-30
GR70371B (es) 1982-09-30
PT70695A (en) 1980-02-01
ES8106521A1 (es) 1981-08-16
ES8106520A1 (es) 1981-08-16
ES487661A0 (es) 1980-12-16
FI800100A (fi) 1980-07-17
DK16480A (da) 1980-07-17
NO800085L (no) 1980-07-17
ES494606A0 (es) 1981-08-16
US4297358A (en) 1981-10-27
ES494604A0 (es) 1981-08-16
JPS5598182A (en) 1980-07-25
ZA80254B (en) 1980-12-31

Similar Documents

Publication Publication Date Title
DE2614406C2 (es)
DE1695556C3 (de) 3-Alkyl-1,2,3,4,4a,9-hexahydropyrazino[1,2-f]morphanthridinderivate
DE3033157A1 (de) 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
CH650782A5 (de) Carbostyrilverbindungen, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
EP0080602A1 (de) Substituierte Benzimidazole, Verfahren zu ihrer Herstellung, ihre Anwendung und sie enthaltende Arzneimittel
EP0658559A1 (de) Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als 5-dipoxygenase und Cyclooxygenaseinhibitoren
DE1958918A1 (de) Chemische Verfahren und Produkte
EP0022078B1 (de) Pyrazolochinoline, Verfahren zu ihrer Herstellung, und pharmazeutische Präparate enthaltend diese Verbindungen
DE69015541T2 (de) Chinolinderivate, deren Herstellung und Verwendung.
EP0062001B1 (de) Acyl-chinolinonderivate, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Präparate und ihre Verwendung
EP0071935B1 (de) 1-Phenyl-2-aminocarbonylindol-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE69008542T2 (de) Chinolinderivate, ihre herstellung und verwendung.
EP0185909B1 (de) 5-Alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0116360B1 (de) 1-Phenyl-2-aminocarbonylindol-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0039519B1 (de) Substituierte Thienotricyclen, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2737407A1 (de) Verfahren zur herstellung neuer benzopyranderivate
EP0072960B1 (de) 1,5-Diphenylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0012925B1 (de) Neue Chinoloncarbonsäure-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
EP0576906A1 (de) Neue Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Antiinflammatorium und Analgeticum
EP0000488A1 (de) 3-Oxaloamino-4-oxo-4H-1-benzopyranderivaten, Verfahren zu deren Herstellung und deren pharmazeutischen Verwendung
DD148776A5 (de) Verfahren zur herstellung neuer phenanthrolinderivate
EP0064255A1 (de) Benzopyranylether, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel und Zwischenprodukte
AT391316B (de) Neue thienyloxy-alkylamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0717044A1 (de) Thienopyridonderivate, deren Herstellung und deren Verwendung als NMDA-Rezeptor Antagonisten
DE2832358C2 (es)